How Xeomin works locally
Xeomin is a botulinum toxin type A product that works by temporarily reducing the small muscle contractions that create moderate to severe frown lines between the eyebrows. Its 'naked' formulation lacks complexing proteins, which may lower the chance of antibody formation over prolonged use. The result develops gradually as muscle activity decreases.
Treatments are brief and focused; our standard appointment is 60 MINUTES to include consultation, planning, and injections. Many clients report less sting during injection compared with other neurotoxins. Most changes become noticeable within days, with the full aesthetic effect typically apparent around two weeks after treatment.
Injection technique and aftercare
Each Xeomin treatment at SL Aesthetic begins with a focused assessment of dynamic facial movement and the specific frown lines to treat. Injections are placed precisely into the muscles driving those lines; the clinician tailors placement and units to the individual's anatomy and movement patterns to achieve balanced softening.
After injections, patients can expect minor, short-lived redness or small bruises at injection sites. If any unexpected symptoms occur, contact the clinic for advice or follow-up. Because Xeomin's effect is temporary, clients typically plan follow-up appointments with their provider to maintain results based on individual goals.
Why choose Xeomin here
SL Aesthetic is located along the Mineral Point Road corridor near West Towne Mall, making Xeomin appointments convenient for commuters, shoppers, students, and nearby residents from Madison, Fitchburg, Middleton, Verona and Monona. The office's proximity to retail and transit stops supports efficient visits before or after errands or work.
When choosing between neurotoxins, clients often weigh formulation and long-term options. Xeomin's purified, protein-free formulation may reduce the theoretical risk of antibody development over time and often causes less sting. A consultation at SL Aesthetic helps determine whether Xeomin is an appropriate option for moderate to severe glabellar lines.
